Penn Medicine MD

6.8K posts

Penn Medicine MD banner
Penn Medicine MD

Penn Medicine MD

@PennMDForum

We share clinical updates about the physicians and providers, research, programs and initiatives at @PennMedicine and @Penn's Perelman School of Medicine.

Philadelphia, PA Katılım Mart 2010
1.5K Takip Edilen6.5K Takipçiler
Penn Medicine MD
Penn Medicine MD@PennMDForum·
From radical hysterectomy to upper abdominal procedures, gain practical experience in advanced gynecologic oncology surgery through expert-guided cadaveric training and individualized coaching. #GynOnc spr.ly/6019BEpygl
English
0
0
1
107
Penn Medicine MD
Penn Medicine MD@PennMDForum·
Treatment selection in acute #leukemia has become increasingly complex as new targeted agents and immunotherapies expand options for patients with AML and ALL. Molecular profiling is now central to individualized care decisions. spr.ly/6018BEH4dE
English
0
0
1
122
Penn Medicine MD
Penn Medicine MD@PennMDForum·
Evolving care models in hematology: Penn Medicine brings gene therapy from clinical trials to practice for hemophilia B, SCD, and β-thalassemia. Read more: spr.ly/6017BDlwQt
English
0
0
2
135
Penn Medicine MD retweetledi
Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉
🚨NEW - AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy #Celltherapy #genetherapy #immunotherapy #CARTCell #AI cell.com/cell/fulltext/…
Bruce Levine, Ph.D. 🇺🇦🥼🔬🧬🧪💉@BLLPHD

🧵/1 AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy @CellPressNews AI did not “invent” a CAR T therapy here. It helped focus the search for a plausible target in a very large haystack of public single-cell and expression data. That distinction matters. The important advance is human expertise plus AI triage, followed by wet lab validation. GPNMB CAR T activity across melanoma, leukemia, and colorectal models is intriguing. The hard human enabled part is demonstrating specificity, safety, clinical translation. @PennMedicine @daniel_baker_j @JonEpsteinLab @AranyLab @carlhjune

English
1
9
19
2.5K
Penn Medicine MD
Penn Medicine MD@PennMDForum·
.@PennMedicine continues to lead the way in #CARTtherapy. In an early-stage clinical trial, a novel application helped two kidney disease patients to receive transplants that were previously improbable. Read about the trial: spr.ly/6010BDda9o
English
0
0
1
247
Penn Medicine MD
Penn Medicine MD@PennMDForum·
.@PennCancer is advancing gynecologic oncology through integrated bench‑to‑bedside research, novel surgical imaging, immunotherapy, and expanded clinical trial access. Explore how innovation is shaping patient care. spr.ly/6010BDjhLo
English
0
0
1
127
Penn Medicine MD
Penn Medicine MD@PennMDForum·
Clinical advances in hemoglobinopathies: Penn Medicine delivers gene therapy approaches enabling transfusion independence and reduced VOEs in SCD. Details: spr.ly/6010BDlXba
English
0
0
0
139
Penn Medicine MD
Penn Medicine MD@PennMDForum·
.@PennMedicine’s Abramson Cancer Center has a strong emphasis on #ovariancancer and innovative resources like tumor biobanking and advanced imaging. It's driving earlier detection and more effective, personalized therapies across gynecologic cancers. spr.ly/6016BDjh54
English
0
0
0
123
Penn Medicine MD
Penn Medicine MD@PennMDForum·
Four thousand liver transplants, the highest in the region. That's 4,000 second chances at life. We're celebrating this milestone from @Penn_Transplant with pride in our transplant team, and deep gratitude for our donors. This wouldn't be possible without either group.
Penn Medicine MD tweet media
English
0
1
2
195
Penn Medicine MD
Penn Medicine MD@PennMDForum·
CAR T cell therapy continues to evolve, with research expanding into earlier-line treatment and next-generation constructs to improve outcomes in hematologic malignancies. Learn more about what’s being researched now: spr.ly/6010BDz00I
English
0
0
1
129
Penn Medicine MD
Penn Medicine MD@PennMDForum·
From armored CAR T cells to allogeneic approaches, emerging innovations are addressing current limitations and shaping the future of cell therapy in oncology. Learn more about what’s coming: spr.ly/6015BDKkEL
English
0
0
1
110
Penn Medicine MD
Penn Medicine MD@PennMDForum·
Bridging clinical expertise and patient voice in aortic care. #AortaDelphia2026 highlighted multidisciplinary collaboration, risk stratification, and longitudinal management for aortic dissection. spr.ly/6012B8FbiA
Penn Medicine MD tweet media
English
0
0
1
121
Penn Medicine MD retweetledi
Penn Medicine Cancer
Penn Medicine Cancer@PennCancer·
An @FDA advisory committee found the benefits of a Truqap combo for advanced prostate cancer outweighed risks. Committee member Kyle Robinson, MD, said doctors have grown accustomed to cross-specialty collabs to address toxicity concerns. @OncNewsCentral spr.ly/6012B8ZPZA
English
0
1
0
337
Penn Medicine MD
Penn Medicine MD@PennMDForum·
Pulsed field ablation (PFA) is redefining AFib treatment—offering myocardial selectivity with near zero risk of collateral injury and promising clinical outcomes. Learn more about this #Afib treatment technique. spr.ly/6018B8m7gK
Penn Medicine MD tweet media
English
0
0
2
107
Penn Medicine MD
Penn Medicine MD@PennMDForum·
From acute stabilization to chronic management, AortaDelphia 2026 underscored integrated care models, patient education, and innovation shaping the future of aortic disease management. spr.ly/6015B8FnSD
Penn Medicine MD tweet media
English
0
0
0
107
Penn Medicine MD
Penn Medicine MD@PennMDForum·
Aortic dissection care doesn’t end after surgery. From acute stabilization to lifelong surveillance, managing aortic dissection is a continuum—not a one-time intervention. Learn how aortic management evolves from emergent care to lifelong monitoring. spr.ly/6015B8brCF
Penn Medicine MD tweet media
English
0
0
0
129
Penn Medicine MD
Penn Medicine MD@PennMDForum·
Big strides in solid tumor cancer care at @PennMedicine—bringing groundbreaking cell therapies like lifileucel to patients with melanoma and rare sarcomas. A glimpse at how innovation is turning breakthroughs into real treatment options. spr.ly/6019B8k8Mz
English
0
0
4
197